Higher-Level Analysis of OCT Features

Justis Ehlers, MD

Show Description +

Justis Ehlers, MD, presents the findings gathered from a higher-order analysis of OCT images taken in the OSPREY study, a phase 2 prospective randomized trial comparing brolucizumab with aflibercept in treatment-naïve patients with wet AMD.

Posted: 7/22/2019

Up Next

The Winning Pitch: The Shark Tank of Retina

David Williams

Rethinking Risk in Fovea-Sparing RRDs

James Major Jr., MD

What Happens When DR Treatment Is Less Aggressive?

Roger A. Goldberg, MD, MBA

Hyperreflective Foci and Pathologic Risk

Bozho Todorich, MD, PhD

Novel Combination Technique for Closing Challenging Macular Holes

Robert Sisk

A Novel Retinal Tamponade

Tommy Stryjewski, Tony Stefater

1-Year Primary Outcome Data From RECOVERY

Charles Wykoff, MD, PhD

Ranibizumab PDS: How LADDER Informed ARCHWAY

Arshad Khanani, MD

Intravitreal Injections and Clinical Resources

Christina Weng, MD

CST Fluctuations in HAWK and HARRIER

Chirag Jhaveri, MD

STAIRWAY: Faricimab for Wet AMD

Philip Ferrone

HARBOR Post-Hoc Analysis: Vision Outcomes and the Presence of Fluid

Nancy Holekamp, MD

Preview to ASRS with Dr. Packo

Kirk Packo, MD

Preview to ASRS 2019 With Dr. Pollack

John Pollack, MD

Back to All Videos

Higher-Level Analysis of OCT Features

Justis Ehlers, MD

Posted: 7/22/2019

Please log in to leave a comment.

Meeting Coverage:

American Society of Retina Specialists Annual Meeting

Higher-Level Analysis of OCT Features

Up Next

Higher-Level Analysis of OCT Features

More From ASRS: 2019 Coverage